Inhibition of Vesivirus Infections in Mammalian Tissue Culture with Antisense Morpholino Oligomers
- 1 October 2001
- journal article
- research article
- Published by Mary Ann Liebert Inc in Antisense and Nucleic Acid Drug Development
- Vol. 11 (5) , 317-325
- https://doi.org/10.1089/108729001753231696
Abstract
Caliciviruses infect and cause disease in animals and humans. They are nonenveloped, positive-stranded RNA viruses with a genome of approximately 7.5 kb that encodes viral proteins in three open reading frames (ORF). Antisense oligomers targeting one of the three ORF of caliciviruses of the genus Vesivirus significantly inhibit viral replication in tissue culture. Porcine kidney and African green monkey kidney cells were infected with Vesivirus isolates SMSV-13 and PCV Pan-1. Phosphorodiamidate morpholino oligomers (PMO) with sequence complementary to the AUG translation start site regions of ORF1, ORF2, and ORF3 were evaluated for their effect on viral titer. Scrape-loading delivered PMO to 50%-70% of the cells of the two cell lines, as measured by fluorescence microscopy and flow cytometry. A PMO targeting ORF3 caused a significant increase in viral titer. A PMO targeting ORF2, a scrambled PMO control sequence, and an unrelated PMO antisense sequence did not alter viral titer. Various PMO sequences antisense to an upstream region of ORF1 were effective in reducing viral titer up to 80% in a dose-dependent and sequence-specific manner. The extent of viral titer reduction was proportional to the delivery of PMO to cells. These observations demonstrate that antisense PMO can disrupt caliciviral gene function in a nucleic acid sequence-specific manner and are potentially effective antiviral agents.Keywords
This publication has 31 references indexed in Scilit:
- Effective targeted gene ‘knockdown’ in zebrafishNature Genetics, 2000
- Intracellular Delivery Strategies for Antisense Phosphorodiamidate Morpholino OligomersAntisense and Nucleic Acid Drug Development, 2000
- Taxonomy of the CalicivirusesThe Journal of Infectious Diseases, 2000
- Herpes Simplex Virus Type 2 Growth and Latency Reactivation by Cocultivation Are Inhibited with Antisense Oligonucleotides Complementary to the Translation Initiation Site of the Large Subunit of Ribonucleotide Reductase (RR1)Antisense and Nucleic Acid Drug Development, 2000
- Evidence of Enhanced Iron Excretion During Systemic Phosphorothioate Oligodeoxynucleotide TreatmentJournal of Toxicology: Clinical Toxicology, 2000
- Bolus Intravenous Injection of Phosphorothioate Oligonucleotides Causes Hypotension by Acting as α1-Adrenergic Receptor AntagonistsToxicology and Applied Pharmacology, 1999
- Growth Inhibition of Cervical Tumor Cells by Antisense Oligodeoxynucleotides Directed to the Human Papillomavirus Type 16 E6 GeneAntisense and Nucleic Acid Drug Development, 1999
- Antisense Morpholino Oligonucleotide Analog Induces Missplicing of C-mycmRNAAntisense and Nucleic Acid Drug Development, 1999
- Effect of TNF-α Antisense Oligomers on Cytokine Production by Primary Murine Alveolar MacrophagesAntisense and Nucleic Acid Drug Development, 1998
- Reaction between Metabolically Activated Acetaminophen and Phosphorothioate OligonucleotidesToxicology and Applied Pharmacology, 1995